Qi-Zhu Tang (Qizhu Tang, Tang Qizhu)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 43

Top Topics

Signaling Pathway

Top Venues

Oxidative medicine and cellular longevity

Journal of translational medicine

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yizhou Feng, Yuan Yuan, Hongxia Xia, Zhaopeng Wang, Yan Che, Zhefu Hu, Jiangyang Deng, Fangfang Li, Qingqing Wu, Zhouyan Bian, Heng Zhou, Difei Shen, Qi-Zhu Tang
OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling. Journal of translational medicine 21 (1) (2023)
Xin Zhang, Can Hu, Zhen-Guo Ma, Min Hu, Xiao-Pin Yuan, Yu-Pei Yuan, Sha-Sha Wang, Chun-Yan Kong, Teng Teng, Qi-Zhu Tang
Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice. Nature communications 14 (1) (2023)
Wen-Jing Li, Han Yan, Zi-Ying Zhou, Nan Zhang, Wen Ding, Hai-Han Liao, Qi-Zhu Tang
Cryptotanshinone Attenuated Pathological Cardiac Remodeling In Vivo and In Vitro Experiments. Oxidative medicine and cellular longevity 2023 (2023)
Zhen-Guo Ma, Yu-Pei Yuan, Di Fan, Xin Zhang, Teng Teng, Peng Song, Chun-Yan Kong, Can Hu, Wen-Ying Wei, Qi-Zhu Tang
IRX2 regulates angiotensin II-induced cardiac fibrosis by transcriptionally activating EGR1 in male mice. Nature communications 14 (1) (2023)
Yizhou Feng, Yuan Yuan, Hongxia Xia, Zhaopeng Wang, Yan Che, Zhefu Hu, Jiangyang Deng, Fangfang Li, Qingqing Wu, Zhouyan Bian, Heng Zhou, Difei Shen, Qi-Zhu Tang
OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling. Journal of translational medicine 21 (1) (2023)
Yizhou Feng, Yuan Yuan, Hongxia Xia, Zhaopeng Wang, Yan Che, Zhefu Hu, Jiangyang Deng, Fangfang Li, Qingqing Wu, Zhouyan Bian, Heng Zhou, Difei Shen, Qi-Zhu Tang
OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling. Journal of translational medicine 21 (1) (2023)
Yizhou Feng, Yuan Yuan, Hongxia Xia, Zhaopeng Wang, Yan Che, Zhefu Hu, Jiangyang Deng, Fangfang Li, Qingqing Wu, Zhouyan Bian, Heng Zhou, Difei Shen, Qi-Zhu Tang
OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling. Journal of translational medicine 21 (1) (2023)
Wen-Jing Li, Han Yan, Zi-Ying Zhou, Nan Zhang, Wen Ding, Hai-Han Liao, Qi-Zhu Tang
Cryptotanshinone Attenuated Pathological Cardiac Remodeling In Vivo and In Vitro Experiments. Oxidative medicine and cellular longevity 2023 (2023)
Yizhou Feng, Yuan Yuan, Hongxia Xia, Zhaopeng Wang, Yan Che, Zhefu Hu, Jiangyang Deng, Fangfang Li, Qingqing Wu, Zhouyan Bian, Heng Zhou, Difei Shen, Qi-Zhu Tang
OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling. Journal of translational medicine 21 (1) (2023)
Sai-Yang Xie, Shi-Qiang Liu, Tong Zhang, Wen-Ke Shi, Yun Xing, Wen-Xi Fang, Min Zhang, Meng-Ya Chen, Si-Chi Xu, Meng-Qi Fan, Lan-Lan Li, Heng Zhang, Nan Zhao, Zhao-Xiang Zeng, Si Chen, Xiao-Feng Zeng, Wei Deng, Qi-Zhu Tang
USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart. Circulation (2023)
Wei Ye, Qi-Zhu Tang, Lei Wang, Chenzhi Fang, Lili Xie, Qi He, Kaiwei Peng
Contribution of CYP19A1, CYP1A1, and CYP1A2 polymorphisms in coronary heart disease risk among the Chinese Han population. Functional & integrative genomics 22 (4) (2022)
Sai-Yang Xie, Min Zhang, Wenke Shi, Yun Xing, Yan Huang, Wen-Xi Fang, Shi-Qiang Liu, Meng-Ya Chen, Tong Zhang, Si Chen, Xiaofeng Zeng, Shasha Wang, Wei Deng, Qi-Zhu Tang
Long-Term Activation of Glucagon-like peptide-1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes. Journal of the American Heart Association 11 (19) (2022)
Zhen Guo, Fang-Yuan Liu, Dan Yang, Ming-Yu Wang, Chen-Fei Li, Nan Tang, Shu-Qing Ma, Peng An, Zheng Yang, Qi-Zhu Tang
Salidroside ameliorates pathological cardiac hypertrophy via TLR4-TAK1-dependent signaling. Phytotherapy research : PTR (2022)
Can Hu, Xin Zhang, Min Hu, Teng Teng, Yu-Pei Yuan, Peng Song, Chun-Yan Kong, Si-Chi Xu, Zhen-Guo Ma, Qi-Zhu Tang
Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice. Aging cell 21 (3) (2022)
Dan Yang, Di Fan, Zhen Guo, Fang-Yuan Liu, Ming-Yu Wang, Peng An, Zheng Yang, Qi-Zhu Tang
SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling. Journal of the American Heart Association 11 (22) (2022)
Yingying Guo, Dan Li, Xian-Feng Cen, Hong-Liang Qiu, Yu-Lan Ma, Yi Liu, Si-Hui Huang, Li-Bo Liu, Man Xu, Qi-Zhu Tang
Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway. Oxidative medicine and cellular longevity 2022 (2022)
Xin Zhang, Can Hu, Xiao-Pin Yuan, Yu-Pei Yuan, Peng Song, Chun-Yan Kong, Teng Teng, Min Hu, Si-Chi Xu, Zhen-Guo Ma, Qi-Zhu Tang
Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity. Cell death & disease 12 (7) (2021)
Hai-Han Liao, Jin-Xiu Zhu, Hong Feng, Jian Ni, Nan Zhang, Si Chen, Huang-Jun Liu, Zheng Yang, Deng Wei, Qi-Zhu Tang
Corrigendum to "Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1". Oxidative medicine and cellular longevity 2021 (2021)
Xie Saiyang, Wu Qingqing, Xu Man, Liu Chen, Zhang Min, Xing Yun, Shi Wenke, Wu Haiming, Zeng Xiaofeng, Chen Si, Guo Haipeng, Deng Wei, Qi-Zhu Tang
Activation of Toll-like receptor 7 provides cardioprotection in septic cardiomyopathy-induced systolic dysfunction. Clinical and translational medicine 11 (1) (2021)
Can Hu, Xin Zhang, Ning Zhang, Wen-Ying Wei, Ling-Li Li, Zhen-Guo Ma, Qi-Zhu Tang
Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity. Clinical and translational medicine 10 (3) (2020)
Zhen Guo, Nan Tang, Fang-Yuan Liu, Zheng Yang, Shu-Qing Ma, Peng An, Hai-Ming Wu, Di Fan, Qi-Zhu Tang
TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy. Journal of cellular and molecular medicine 24 (18) (2020)
Chen Cao, Hui-Min Liu, Wei Li, Yang Wu, Yan Leng, Rui Xue, Rong Chen, Ling-Hua Tang, Qian Sun, Zhong-Yuan Xia, Qi-Zhu Tang, Di-Fei Shen, Qing-Tao Meng
Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning. Acta cirurgica brasileira 35 (1) (2020)
Dan Yang, Han-Qing Liu, Fang-Yuan Liu, Nan Tang, Zhen Guo, Shu-Qing Ma, Peng An, Ming-Yu Wang, Hai-Ming Wu, Zheng Yang, Di Fan, Qi-Zhu Tang
Critical roles of macrophages in pressure overload-induced cardiac remodeling. Journal of molecular medicine (Berlin, Germany) 99 (1) (2020)
Ya-Ge Jin, Heng Zhou, Di Fan, Yan Che, Zhao-Peng Wang, Sha-Sha Wang, Qi-Zhu Tang
TMEM173 protects against pressure overload-induced cardiac hypertrophy by modulating autophagy. Journal of cellular physiology 236 (7) (2020)
Ling-Li Li, Li Wei, Ning Zhang, Wen-Ying Wei, Can Hu, Deng Wei, Qi-Zhu Tang
Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway. BioMed research international 2020 (2020)
Hui-Bo Wang, Si-Hui Huang, Man Xu, Jun Yang, Jian Yang, Ming-Xin Liu, Chun-Xia Wan, Hai-Han Liao, Di Fan, Qi-Zhu Tang
Galangin ameliorates cardiac remodeling via the MEK1/2-ERK1/2 and PI3K-AKT pathways. Journal of cellular physiology (2019)
Ming-Xia Duan, Heng Zhou, Qing-Qing Wu, Chen Liu, Yang Xiao, Deng Wei, Qi-Zhu Tang
Andrographolide Protects against HG-Induced Inflammation, Apoptosis, Migration, and Impairment of Angiogenesis via PI3K/AKT-eNOS Signalling in HUVECs. Mediators of inflammation 2019 (2019)
Qing-Qing Wu, Deng Wei, Yang Xiao, Jiao-Jiao Chen, Chen Liu, Juan Wang, Yankai Guo, Mingxia Duan, Zhulan Cai, Saiyang Xie, Yuan Yuan, Qi-Zhu Tang
The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPARα. Oxidative medicine and cellular longevity 2019 (2019)
Chen Liu, Qing-Qing Wu, Zhu-Lan Cai, Sai-Yang Xie, Ming-Xia Duan, Qing-Wen Xie, Yuan Yuan, Wei Deng, Qi-Zhu Tang
Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway. Journal of cellular and molecular medicine 23 (9) (2019)
Yan-Yan Meng, Yu-Pei Yuan, Xin Zhang, Chun-Yan Kong, Peng Song, Zhen-Guo Ma, Qi-Zhu Tang
Protection against Doxorubicin-Induced Cytotoxicity by Geniposide Involves AMPKα Signaling Pathway. Oxidative medicine and cellular longevity 2019 (2019)
Hai-Han Liao, Nan Zhang, Yan-Yan Meng, Hong Feng, Jing-Jing Yang, Wen-Jin Li, Si Chen, Hai-Ming Wu, Deng Wei, Qi-Zhu Tang
Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway. Oxidative medicine and cellular longevity 2019 (2019)
Hui-Bo Wang, Ming-Xia Duan, Man Xu, Si-Hui Huang, Jun Yang, Jian Yang, Li-Bo Liu, Rong Huang, Chun-Xia Wan, Zhen-Guo Ma, Qing-Qing Wu, Qi-Zhu Tang
Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway. Journal of cellular and molecular medicine 23 (8) (2019)
Jie Yan, Si-Chi Xu, Chun-Yan Kong, Xiao-Yang Zhou, Zhou-Yan Bian, Ling Yan, Qi-Zhu Tang
Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice. PPAR research 2019 (2019)
Ning Li, Haiming Wu, Rong-Xin Geng, Qi-Zhu Tang
Identification of Core Gene Biomarkers in Patients with Diabetic Cardiomyopathy. Disease markers 2018 (2018)
Zheng Yang, Qing-Qing Wu, Yang Xiao, Ming Xia Duan, Chen Liu, Yuan Yuan, Yan-Yan Meng, Hai Han Liao, Qi-Zhu Tang
Aucubin Protects against Myocardial Infarction-Induced Cardiac Remodeling via nNOS/NO-Regulated Oxidative Stress. Oxidative medicine and cellular longevity 2018 (2018)
Zhen-Guo Ma, Chun-Yan Kong, Peng Song, Xin Zhang, Yu-Pei Yuan, Qi-Zhu Tang
Geniposide Protects against Obesity-Related Cardiac Injury through AMPKα- and Sirt1-Dependent Mechanisms. Oxidative medicine and cellular longevity 2018 (2018)
Heng Zhou, Ning Li, Yuan Yuan, Ya-Ge Jin, Haipeng Guo, Wei Deng, Qi-Zhu Tang
Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target. Basic research in cardiology 113 (5) (2018)
Qing-Qing Wu, Yang Xiao, Ming-Xia Duan, Yuan Yuan, Xiao-Han Jiang, Zheng Yang, Hai-Han Liao, Wei Deng, Qi-Zhu Tang
Aucubin protects against pressure overload-induced cardiac remodelling via the β3 -adrenoceptor-neuronal NOS cascades. British journal of pharmacology 175 (9) (2018)
Hai-Han Liao, Jin-Xiu Zhu, Hong Feng, Jian Ni, Nan Zhang, Si Chen, Huang-Jun Liu, Zheng Yang, Wei Deng, Qi-Zhu Tang
Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1. Oxidative medicine and cellular longevity 2017 (2017)
Si-Chi Xu, Zhen-Guo Ma, Wen-Ying Wei, Yu-Pei Yuan, Qi-Zhu Tang
Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis. PPAR research 2017 (2017)
Ya-Ge Jin, Yuan Yuan, Qing-Qing Wu, Ning Zhang, Di Fan, Yan Che, Zhao-Peng Wang, Yang Xiao, Sha-Sha Wang, Qi-Zhu Tang
Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition. PPAR research 2017 (2017)
Di Fan, Zheng Yang, Yuan Yuan, Qing-Qing Wu, Man Xu, Ya-Ge Jin, Qi-Zhu Tang
Sesamin prevents apoptosis and inflammation after experimental myocardial infarction by JNK and NF-κB pathways. Food & function 8 (8) (2017)
Ning Li, Heng Zhou, Qi-Zhu Tang
Red Blood Cell Distribution Width: A Novel Predictive Indicator for Cardiovascular and Cerebrovascular Diseases. Disease markers 2017 (2017)